Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Pentagon Taps Gavin Kliger as CDO Amid AI Push
Gavin Kliger will help coordinate the Pentagon’s growing AI initiatives as leaders overhaul acquisition processes to deliver advanced capabilities faster.
3m read -
Army’s FUZE Program Speeds Path to Fielding Emerging Tech
Director Matthew Willis says FUZE is reshaping defense innovation by funding prototypes quickly and scaling successful tech in months instead of years.
4m read -
New Navy Platform Aims to Improve Medical Recordkeeping at Sea
The Operational Medical Care Delivery Platform captures patient care data aboard ships and integrates it with U.S.-based military medical networks.
4m read -
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch
